Pepinemab

DB15155Investigational

Pepinemab is under investigation in clinical trial NCT03769155 (VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma).

Mechanism: Pharmacologically active on Semaphorin-4D
Curator reviewed
Also known as: MOAB VX15/2503 · VX15/2503

Resolves to

Compound

UNIIBPZ4A29SYECAS2097151-87-4

Targets

Q92854SEMA4D

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

13Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pepinemab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account